| Literature DB >> 34987575 |
Mohamed A Hassan-Kadle1, Abdulkamil Abdullahi Adani2, Hasan Huseyin Eker3, Esra Keles4, Marian Muse Osman5, Hussein Mahdi Ahmed2, Şeyma Görçin Karaketir6.
Abstract
BACKGROUND: Thyroid disorder is one of the most common noncommunicable diseases worldwide and neglected public health issues in Somalia. The aim of the study thus was to investigate the thyroid disorders in patients attending to the largest tertiary referral hospital in Somalia.Entities:
Year: 2021 PMID: 34987575 PMCID: PMC8720598 DOI: 10.1155/2021/7154250
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Baseline characteristics of the patients (n = 971), January 2017–December 2019, Somalia.
|
| |
|
| |
| Gender | |
| Female | 650 (66.6) |
| Male | 326 (33.4) |
| Age (years, mean ± SD) | 47 ± 18.5 |
| Age groups | |
| 18–30 | 236 (24.2) |
| 31–50 | 350 (35.9) |
| 51–70 | 269 (27.6) |
| 71–90 | 116 (11.9) |
| ≥91 | 5 (0.5) |
| Diagnosis | |
| Subclinical hyperthyroidism | 55 (5.7) |
| Hyperthyroidism | 74 (7.6) |
| Euthyroid sick syndrome | 571 (58.8) |
| Hypothyroidism | 150 (15.4) |
| Subclinical hypothyroidism | 121 (12.5) |
| Comorbidities | |
| DM | 131 (13.4) |
| HIV | 101 (10.4) |
| Malaria | 48 (4.9) |
| HIV and malaria | 44 (4.5) |
| Type | |
| Benign | 954 (97.8) |
| Malignant | 22 (2.2) |
| Differentiated | 2 (0.2) |
| Follicular | 9 (0.9) |
| Papillary | 11 (1.1) |
Figure 1Distribution of thyroid disease cases (n = 976) by histopathological results and thyroid function disorders' subgroups, January 2017–December 2019, Somalia.
Baseline characteristics of the patients according to thyroid function disorders (n = 971), January 2017–December 2019, Somalia.
| Subclinical hyperthyroidism ( | Hyperthyroidism ( | Euthyroid sick syndrome ( | Hypothyroidism ( | Subclinical hypothyroidism ( | |
|
| |||||
| Gender ( | |||||
| Female | 41 (6.3) | 62 (9.6) | 348 (53.8) | 106 (16.4) | 90 (13.9) |
| Male | 14 (4.3) | 12 (3.7) | 223 (68.8) | 44 (13.6) | 31 (9.6) |
| Age (mean ± SD), years | 44 ± 16.1 | 38 ± 14.6 | 49 ± 19.6 | 45 ± 15.3 | 48 ± 18.8 |
| Age groups ( | |||||
| 18–30 | 11 (4.7) | 28 (12) | 140 (59.8) | 30 (12.8) | 25 (10.7) |
| 31–50 | 29 (8.4) | 32 (9.2) | 166 (47.8) | 73 (21) | 47 (13.5) |
| 51–70 | 11 (4.1) | 11 (4.1) | 176 (65.4) | 36 (13.4) | 35 (13) |
| 71–90 | 4 (3.4) | 3 (2.6) | 86 (74.1) | 11 (9.5) | 12 (10.3) |
| ≥91 | 0 (0.0) | 0 (0.0) | 3 (60) | 0 (0.0) | 2 (40) |
| Histopathological results ( | |||||
| Thyroid cancer | 1 (4.5) | 0 (0.0) | 11 (50) | 5 (22.7) | 5 (22.7) |
| Comorbidities ( | |||||
| Malaria | 6 (6.0) | 1 (1.0) | 63 (63) | 15 (15) | 15 (15) |
| HIV | 3 (6.4) | 0 | 30 (63.8) | 4 (8.5) | 10 (21.5) |
| Malaria + HIV | 3 (7) | 0 | 27 (62.8) | 3 (7) | 10 (23.5) |
| Diabetes mellitus | 15 (11.5) | 7 (5.4) | 77 (59.2) | 15 (11.5) | 16 (12.3) |
p ≤ 0.001.
Figure 2Distribution of thyroid cancers by comorbidities (n = 22), January 2017–December 2019, Somalia.
Figure 3Age distribution of patients by gender (n = 976), January 2017–December 2019, Somalia.